donor stem cell
Cell therapyexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 11, 2003 (NCT00074490)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- donor stem cell
- hla-mismatched donor stem cells
- partially hla-matched unrelated donor stem cells
- related donor stem cell
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02189824 | Phase 1 | Aug 1, 2014 | Melbourne Health, University of Queensland, University of Sydney |
| NCT00810602 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2009 | University of Michigan |
| NCT00074490 | Phase 2 | Dec 11, 2003 | National Cancer Institute (NCI) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Melbourne Health | Academic/Hospital | 1 | 0 | 1 | 2014 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2003 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2009 |
| University of Queensland | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Sydney | Academic/Hospital | 1 | 1 | 1 | 2014 |
5 organizations
Page 1 / 1